6-Methyl-9-(2-β-C-methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine

• UNSPSC Description:

  6-Methyl-9-(2-β-C-methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

• Target Antigen:

  Nucleoside Antimetabolite/Analog

• Type:

  Oligonucleotides

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/6-methyl-9-2-β-c-methyl-2-3-5-tri-o-benzoyl-β-d-ribofuranosyl-purine.html

• Solubility:

  10 mM in DMSO

• Smiles:

  C[C@@]1(OC(C2=CC=CC=C2)=O)[C@H](OC(C3=CC=CC=C3)=O)[C@@H](COC(C4=CC=CC=C4)=O)O[C@H]1N5C=NC6=C5N=CN=C6C

• Molecular Weight:

  592.60

• References & Citations:

  [1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2095417-61-9